Clinical Scorecard: Retinal Disease Prevalence Study Reveals Gaps
At a Glance
| Category | Detail |
|---|---|
| Condition | Age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic macular edema (DME), retinal vein occlusion (RVO) |
| Key Mechanisms | Prevalence disparities by race, sex, and geography; significant healthcare burden |
| Target Population | Patients aged 40 years and older |
| Care Setting | Ophthalmology clinics, general healthcare settings |
Key Highlights
- 21.9 million patients aged 40+ living with AMD in 2022, crude prevalence of 13.6%
- Higher prevalence of retinal conditions in male patients compared to females
- Significant racial disparities in prevalence rates across conditions
- State-level variation in prevalence and specialist availability
- Estimated annual payer costs for retinal diseases exceed $30 billion
Guideline-Based Recommendations
Diagnosis
- Utilize population-based studies and claims data for accurate prevalence assessment
- Consider demographic factors in diagnosis and treatment planning
Management
- Address disparities in access to care and treatment for retinal diseases
- Enhance availability of retina specialists in underserved areas
Monitoring & Follow-up
- Regularly assess prevalence data to inform resource allocation and healthcare planning
- Monitor patient outcomes across different demographic groups
Risks
- Underrepresentation of uninsured populations in claims data
- Potential inaccuracies due to outdated data sources and modeling assumptions
Patient & Prescribing Data
Patients aged 40 years and older with retinal diseases
Focus on improving access and outcomes for diverse racial and geographic populations
Clinical Best Practices
- Implement targeted outreach programs to address disparities in retinal disease prevalence
- Utilize comprehensive data to inform clinical decision-making and resource planning
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.